DexCom (DXCM) Stock Highlights

118.77 | +0.31%

2024-06-02 22:31:59

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem.

Statistics

Range Today

116.26 121.47

Volume Today 6.07M

Range 1 Year

74.75 142

Volume 1 Year 888.3M

Range 3 Year

66.89 573.01

Volume 3 Year 2.32B

Range 10 Year

8.03 573.01

Volume 10 Year 9.98B

Highlights

Market Capitalization 47.23B (large)

Floating Shares 393.83M

Current Price 118.77

Price To Earnings 77.14

Price To Revenue 12.3

Price To Book 20.94

Earnings Per Share 1.54

Payout Ratio 0%

Performance

Latest +0.31%

1 Month -5.89%

3 Months -2.46%

6 Months +3.97%

1 Year +4.39%

3 Years +27.98%

5 Years +299.23%

10 Years +1312.25%

Benchmarks

Market Capitalization

5 / 58

Gross Profits

12 / 52

Total Revenue

13 / 57

Total Rank

41 / 58

Free Cashflow

7 / 56

Performance 5 years

4 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.